Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
cBrain A/S is a Danish software engineering company specializing in digital transformation solutions for government organizations. It develops and delivers the cBrain F2® platform, a fully integrated, commercial off-the-shelf (COTS) software designed specifically for public sector workflows to enable fast-track digitalization at scale. The platform streamlines processes such as case management, records and document management, permitting, grants and subsidies, inspections, audits, and HR functions, while incorporating AI tools like cBrain F2® AI Expert and AI Assistant for enhanced efficiency. Tailored initially in collaboration with Danish ministries—serving 21 of 24—cBrain F2® supports over 100 government entities across five continents, including agencies in Europe, Africa, and partnerships like UNDP for accelerating digital transformation. Key applications span policy areas like climate and environment, tax and finance, education, business affairs, labor markets, and culture. Founded over 20 years ago and headquartered in Copenhagen, cBrain A/S plays a pivotal role in modernizing public administration, fostering transparent and accountable institutions through configurable, no-code solutions that reduce processing times and boost productivity.
DKK 49.30
DKK 2.10 (-4.09%)
Price from 9 days ago
23.37% operating margin is above average. ROIC at 13.11%.
Revenue declined 6.2% YoY. Margins deteriorated 9.6pp alongside, both lines moving the wrong way.
ROIC dropped from 21.48% to 13.11%, capital efficiency is deteriorating. Operating margin contracted 9.6pp YoY, cost discipline may be slipping.
22.8x earnings, 17.1x FCF. Valuation is in a reasonable range. The main question is whether the business can re-accelerate or if current trajectory is already priced in.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
DKK 251M
▼ -6.2% YoY
Net Income (TTM)
DKK 43M
▼ -33.5% YoY
Op. Margin
23.37%
▼ -9.6pp YoY
ROIC
13.11%
▼ -8.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
DKK 57M
▲ +176.0% YoY
Op. Cash Flow (TTM)
DKK 85M
▲ +11.7% YoY
Net Debt
-DKK 14M
Net Cash Position
Cash & Equiv.
DKK 42M
3Y CAGR: +10.2%
Continue Research
At a P/E of 22.8 and a price-to-free-cash-flow of 17.1, cBrain A/S (CBRAIN.XCSE) trades below a two-stage DCF intrinsic value of about DKK 102.41 per share, so at DKK 49.30 the stock looks undervalued (107.7% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, cBrain A/S scores 61/100 on Intrinsiqq's quality scorecard (a solid business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 1.3%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about DKK 102.41 per share for CBRAIN.XCSE, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around DKK 76.81. At today's DKK 49.30, that puts the stock about 107.7% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
cBrain A/S scores 61 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a solid business on these measures. Recent fundamentals include a 23.4% operating margin and a 13.1% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, cBrain A/S pays a regular dividend of about DKK 0.64 per share per year (typically in quarterly installments), a yield of roughly 1.3% at the current price. That is a payout ratio of about 29.0% of earnings, so the dividend is amply covered by earnings. cBrain A/S has grown the dividend at roughly 46.2% a year over the past few years. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For CBRAIN.XCSE's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. CBRAIN.XCSE currently trades below its estimated intrinsic value and scores 61/100 on quality (solid). It also yields about 1.3%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.